Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil-dexmedetomidine vs Dexmedetomidine-fentanyl Sedation in Fetoscopic Procedures
NCT05654064Withdrawn
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Apr 2022
- Primary completion
- Apr 2024
- Modality
- Orthosteric Ligands
01
Overview
Trial of remifentanil, dexmedetomidine and fentanyl (2 arms), sponsored by Cincinnati Children's Hospital Medical Center. Primary endpoints: Surgeon satisfaction with sedation protocol and Patient satisfaction with sedation protocol. Planned start Apr 2022; status: withdrawn.
02
Drugs
remifentanildexmedetomidinefentanyl
Beyond the preview
Go deeper on NCT05654064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05654064.